Cargando…
Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism
BACKGROUND: Most cancers favor glycolytic-based glucose metabolism. Hexokinase-2 (HK2), the first glycolytic rate-limiting enzyme, shows limited expression in normal adult tissues but is overexpressed in many tumor tissues, including ovarian cancer. HK2 has been shown to be correlated with the progr...
Autores principales: | Zhang, Meng, Liu, Qiyu, Zhang, Mingxing, Cao, Cong, Liu, Xiaoxia, Zhang, Mengyu, Li, Guiling, Xu, Congjian, Zhang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648390/ https://www.ncbi.nlm.nih.gov/pubmed/33160373 http://dx.doi.org/10.1186/s12951-020-00720-4 |
Ejemplares similares
-
Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy
por: Zhang, Mengyu, et al.
Publicado: (2018) -
Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor
por: Duan, Jia, et al.
Publicado: (2023) -
Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated nanoparticle system improves its specificity and efficacy in ovarian clear cell carcinoma in vitro
por: Hong, Shanshan, et al.
Publicado: (2013) -
SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis
por: Shao, Meng, et al.
Publicado: (2020) -
How Do Hexokinases Inhibit Receptor-Mediated Apoptosis?
por: Schoeniger, Axel, et al.
Publicado: (2022)